[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"0a0a11c871ad7a9ab1117e353acf19ecd07a2653027ddf847ed370482aa10d60","course_id":"PHARMACY 535","course_uid":"course_9fa6a65e7ee4a01d229ac349","catalog_version_id":"9a06661d29f3d46a1654c81dcd643ce5afcd74287d859323f7b90cfee1a4b666","course_number":535,"subjects":["PHARMACY"],"title":"CIRCULATION SCIENCE AND THERAPEUTICS","description":"Integration of pharmacologic knowledge and clinical decision-making to optimize patient management of cardiovascular diseases. Emphasis on patient assessment and provision of evidence-based practices through application of pharmacotherapy principles, and drug monitoring to support person-centered care.","requirements_text":"PHARMACY 435","official_learning_outcomes_json":"[]"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"0a0a11c871ad7a9ab1117e353acf19ecd07a2653027ddf847ed370482aa10d60","course_id":"PHARMACY 535","course_uid":"course_9fa6a65e7ee4a01d229ac349","catalog_version_id":"9a06661d29f3d46a1654c81dcd643ce5afcd74287d859323f7b90cfee1a4b666","course_number":535,"subjects":["PHARMACY"],"title":"CIRCULATION SCIENCE AND THERAPEUTICS","description":"Integration of pharmacologic knowledge and clinical decision-making to optimize patient management of cardiovascular diseases. Emphasis on patient assessment and provision of evidence-based practices through application of pharmacotherapy principles, and drug monitoring to support person-centered care.","requirements_text":"PHARMACY 435","official_learning_outcomes_json":"[]"},{"run_id":"20261014T203208-0851c9a1","semester":"1274","observed_at":"2026-10-14 17:50:09.728220+00:00","record_version_id":"9f168afe8657210fe8953a67aa4fadb40aeba3eb3f92c48ca4429f76dec314bd","course_id":"PHARMACY 535","course_uid":"course_9fa6a65e7ee4a01d229ac349","catalog_version_id":"83b24b6f961f0a27782d781745a36ccb85c93230e58219164486d58c1962f2a5","course_number":535,"subjects":["PHARMACY"],"title":"CIRCULATION SCIENCE AND THERAPEUTICS","description":"Integration of pharmacologic knowledge and clinical decision-making to optimize patient management of cardiovascular diseases. Emphasis on patient assessment and provision of evidence-based practices through application of pharmacotherapy principles, and drug monitoring to support person-centered care.","requirements_text":"PHARMACY 435","official_learning_outcomes_json":"[{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:09.093776+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/pharmacy/\",\"term\":null,\"text\":\"Assess circulatory health conditions by evaluating diagnostic criteria, risk factors, etiology, and treatment goals.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:09.093776+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/pharmacy/\",\"term\":null,\"text\":\"Differentiate among the therapeutic drug classes used for cardiovascular conditions based on mechanisms of action, clinical use, adverse effects, contraindications, interactions, and dosage forms used for cardiovascular conditions.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:09.093776+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/pharmacy/\",\"term\":null,\"text\":\"Explain why a drug is selected for a cardiovascular condition or person based on its properties.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:09.093776+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/pharmacy/\",\"term\":null,\"text\":\"Design a person-centered care plan consisting of both drug and non-drug elements appropriate for an individual with cardiovascular conditions using evidence-based principles and guidelines.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:09.093776+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/pharmacy/\",\"term\":null,\"text\":\"Evaluate a person-centered care plan to optimize safety and efficacy, considering patient-specific factors, to improve therapeutic outcomes for cardiovascular conditions.\"}]"}]